Tenor Capital Management »

Itron shares owned by Tenor Capital Management

Quarter-by-quarter ownership of Itron shares owned by Tenor Capital Management from 13F filings

Historical chart of Tenor Capital Management investment in Itron

Tip: Access up to 7 years of quarterly data

All positions including Itron held by Tenor Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Itron by Tenor Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $15M 15M 1.01

More positions owned by Tenor Capital Management

Lumentum Hldgs Note 0.500%12/1 (Principal)
Teladoc Health Note 1.250% 6/0 (Principal)
Unity Software Note 11/1 (Principal)
Mirum Pharmaceuticals Note 4.000% 5/0 (Principal)
Conmed Corp Note 2.250% 6/1 (Principal)
Shake Shack Note 3/0 (Principal)
Ventas Rlty Ltd Partnership Note 3.750% 6/0 (Principal)
Akamai Technologies Note 0.375% 9/0 (Principal)
Biomarin Pharmaceutical Note 1.250% 5/1 (Principal)
Jbt Marel Corporation Note 0.250% 5/1 (Principal)
Neogenomics Note 0.250% 1/1 (Principal)
Rapid7 Note 0.250% 3/1 (Principal)
Jazz Investments I Note 2.000% 6/1 (Principal)
Ugi Corp Note 5.000% 6/0 (Principal)
Akamai Technologies Note 1.125% 2/1 (Principal)

View all positions for Tenor Capital Management

Top funds holding Itron

Wolverine Asset Management
Aequim Alternative Investments
Zazove Associates
Wellesley Investment Advisors
Steelhead Partners
Calamos Advisors
Advent Capital Management
Mirabaud Asset Management
Alberta Investment Management Corporation
M&G
Man Group
State Street Corporation
Tenor Capital Management
BlackRock
Citadel Advisors

View all funds holding Itron